ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Shri Ahimsa Naturals Limited concluded its 36th Annual General Meeting on September 14, 2026. Shareholders transacted business regarding financial statements, director re-appointment, and auditor remuneration.
Shri Ahimsa Naturals Limited has scheduled its 36th Annual General Meeting for September 14, 2026. The meeting will address financial adoption and cost auditor ratification.
Shri Ahimsa Naturals Limited submitted its Monitoring Agency Report for Q1 FY27. The company reports no deviations in the utilization of its Rs.50.02 Crore IPO proceeds.
Shri Ahimsa Naturals Limited clarified queries regarding its financial results, correcting a clerical error and rectifying an XBRL mismatch. The company confirmed the results were audited.
Shri Ahimsa Naturals Limited filed its annual Structured Digital Database (SDD) compliance certificate for FY 2025-26. The company confirmed full adherence to SEBI Insider Trading regulations.
Shri Ahimsa Naturals approved a ₹70 Crore capacity enhancement for its Jaipur manufacturing plant. Commissioning is scheduled for March 2027 to drive operational efficiency.
Shri Ahimsa Naturals approved the re-appointment of internal and cost auditors during its board meeting. Both appointments are effective immediately for a twelve-month tenure.
Shri Ahimsa Naturals is pivoting to an integrated model, expanding caffeine capacity 3x via greenfield projects. FY26 revenue reached ₹123 Cr with 35% EBITDA margins.
Shri Ahimsa Naturals reported ₹123.3 Crore revenue for FY26, up 29% YoY. Growth was driven by robust volume expansion and improved realizations in natural caffeine.
Shri Ahimsa Naturals Ltd reported revenue from operations of ₹62.8 Cr (+14.0% YoY) and net profit of ₹14.6 Cr (+19.7% YoY) for H2 FY26.
Shri Ahimsa Naturals reported FY26 financial results and approved a ₹70 Crore manufacturing plant enhancement. Project commissioning in Jaipur is scheduled for March 2027.
Shri Ahimsa Naturals allotted 3,77,600 equity shares following warrant conversions at Rs. 227 each. This ₹8.57 Crore issuance increases total paid-up capital for growth.
Shri Ahimsa Naturals allotted 3,77,600 equity shares following a Rs. 6.43 Crore warrant exercise. The conversion strengthens equity capital while diluting existing shareholding.
Promoter Sumit Jain acquired 3,96,000 shares from Nemi Chand Jain via an off-market gift. Aggregate promoter group holding remains unchanged after this internal transfer.
Shri Ahimsa Naturals Limited submitted a clarification to the NSE regarding its FY2025 financial results, addressing queries on comparative figures and document legibility. The company reported a consolidated revenue of ₹95.81 Crore and a profit of ₹21.90 Crore for the year. The auditor highlighted pending land agreements and insurance claims in an Emphasis of Matter.